Early Career Researchers invited to take part in Regener8 company visits programme

Date: June 14, 2014

First visit will include opportunity for ECRs to present to industry experts

Early career researchers are being encouraged to take part in a series of company visits organised by Regener8, which will provide an opportunity for them to pitch their work to leading companies working in the development of novel regenerative therapies.

The first visit will be to the Smith and Nephew Research Centre in York on Tuesday 1 July and will include presentations from Smith and Nephew, a tour of the Research Centre and the opportunity for networking with Smith and Nephew staff.

The confirmed programme is:

14.45 Arrival at RC
15.00 Welcome and introductions
15.15 S&N presentation (with questions) – Tim Morley
15.50 Regener8 presentation – Mike Raxworthy
16.00 Site tour
16.30 Presentations from 3 ECRs (10 min each)
17.00 Networking and refreshments
18.00 Depart

The day will also include short presentations to Smith and Nephew from up to 4 Early Career Researchers on their current project work.

Submissions are therefore sought from ECRs working in any of the following areas:
• Musculoskeletal diseases and repair
• Wound repair
• Autologous cell therapies
• Regenerative devices.

Abstract should be no more than 200 words describing the clinical problem or target, the proposed technology solution, data generated (or workplan to generate) and expected steps to translation. Please ensure the abstract is non-confidential and supervisor’s permission is obtained. Abstracts should be submitted by the end of Friday 27 June.

Places on the visit are limited to a maximum of 12. If you are an Early Career Researcher working in the areas listed above and would like to take part, please contact Mike Raxworthy, Regener8’s Operations Director, by email

A full programme of visits to other Regener8 Industry members is now being finalised. We expect to be able to announce a programme of visits extending to July 2015 within the next month.

Further information can be obtained from Clare Green ( or Mike Raxworthy.

Back to News Overview